Mitochondrial translocation of α-synuclein is promoted by intracellular acidification

Experimental Cell Research

Volumn 314, Issue 10, 2008, Pages 2076-2089

  Cole, Nelson B ^a   DiEuliis, Diane ^b   Leo, Paul ^a   Mitchell, Drake C ^c   Nussbaum, Robert L ^a  

^a NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Metabolic dysfunction; Mitochondria; Oxidative stress; Parkinson's disease; pH; Synuclein

Indexed keywords

ALPHA SYNUCLEIN; CARDIOLIPIN;

ACIDIFICATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; CELL PH; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; HOMEOSTASIS; METABOLIC STRESS; MITOCHONDRION; MOUSE; NERVE CELL; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

EID: 44749085250     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yexcr.2008.03.012     Document Type: Article

References (70)

1. Abou-Sleiman P.M., Muqit M.M., and Wood N.W. Expanding insights of mitochondrial dysfunction in Parkinson's disease. Nat. Rev. Neurosci. 7 (2006) 207-219
2. Lin M.T., and Beal M.F. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443 (2006) 787-795
3. Betarbet R., Sherer T.B., Di Monte D.A., and Greenamyre J.T. Mechanistic approaches to Parkinson's disease pathogenesis. Brain Pathol. 12 (2002) 499-510
4. Przedborski S., Tieu K., Perier C., and Vila M. MPTP as a mitochondrial neurotoxic model of Parkinson's disease. J. Bioenerg. Biomembr. 36 (2004) 375-379
5. Sherer T.B., Richardson J.R., Testa C.M., Seo B.B., Panov A.V., Yagi T., Matsuno-Yagi A., Miller G.W., and Greenamyre J.T. Mechanism of toxicity of pesticides acting at complex I: relevance to environmental etiologies of Parkinson's disease. J. Neurochem. 100 (2007) 1469-1479
6. Hoglinger G.U., Carrard G., Michel P.P., Medja F., Lombes A., Ruberg M., Friguet B., and Hirsch E.C. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease. J. Neurochem. 86 (2003) 1297-1307
7. Sullivan P.G., Dragicevic N.B., Deng J.H., Bai Y., Dimayuga E., Ding Q., Chen Q., Bruce-Keller A.J., and Keller J.N. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J. Biol. Chem. 279 (2004) 20699-20707
8. Valente E.M., Abou-Sleiman P.M., Caputo V., Muqit M.M., Harvey K., Gispert S., Ali Z., Del Turco D., Bentivoglio A.R., Healy D.G., Albanese A., Nussbaum R., Gonzalez-Maldonado R., Deller T., Salvi S., Cortelli P., Gilks W.P., Latchman D.S., Harvey R.J., Dallapiccola B., Auburger G., and Wood N.W. Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304 (2004) 1158-1160
9. Canet-Aviles R.M., Wilson M.A., Miller D.W., Ahmad R., McLendon C., Bandyopadhyay S., Baptista M.J., Ringe D., Petsko G.A., and Cookson M.R. The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 9103-9108
10. Kim R.H., Smith P.D., Aleyasin H., Hayley S., Mount M.P., Pownall S., Wakeham A., You-Ten A.J., Kalia S.K., Horne P., Westaway D., Lozano A.M., Anisman H., Park D.S., and Mak T.W. Hypersensitivity of DJ-1-deficient mice to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyrindine (MPTP) and oxidative stress. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 5215-5220
11. Greene J.C., Whitworth A.J., Kuo I., Andrews L.A., Feany M.B., and Pallanck L.J. Mitochondrial pathology and apoptotic muscle degeneration in Drosophila parkin mutants. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 4078-4083
12. Palacino J.J., Sagi D., Goldberg M.S., Krauss S., Motz C., Wacker M., Klose J., and Shen J. Mitochondrial dysfunction and oxidative damage in parkin-deficient mice. J. Biol. Chem. 279 (2004) 18614-18622
13. Strauss K.M., Martins L.M., Plun-Favreau H., Marx F.P., Kautzmann S., Berg D., Gasser T., Wszolek Z., Muller T., Bornemann A., Wolburg H., Downward J., Riess O., Schulz J.B., and Kruger R. Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14 (2005) 2099-2111
14. Schapira A.H., Cooper J.M., Dexter D., Clark J.B., Jenner P., and Marsden C.D. Mitochondrial complex I deficiency in Parkinson's disease. J. Neurochem. 54 (1990) 823-827
15. Mizuno Y., Yoshino H., Ikebe S., Hattori N., Kobayashi T., Shimoda-Matsubayashi S., Matsumine H., and Kondo T. Mitochondrial dysfunction in Parkinson's disease. Ann. Neurol. 44 (1998) S99-S109
16. Lee M., Hyun D., Halliwell B., and Jenner P. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. J. Neurochem. 76 (2001) 998-1009
17. Li W., and Lee M.K. Antiapoptotic property of human alpha-synuclein in neuronal cell lines is associated with the inhibition of caspase-3 but not caspase-9 activity. J. Neurochem. 93 (2005) 1542-1550
18. Tanaka Y., Engelender S., Igarashi S., Rao R.K., Wanner T., Tanzi R.E., Sawa A., Dawson V.L., Dawson T.M., and Ross C.A. Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis. Hum. Mol. Genet. 10 (2001) 919-926
19. Jiang H., Wu Y.C., Nakamura M., Liang Y., Tanaka Y., Holmes S., Dawson V.L., Dawson T.M., Ross C.A., and Smith W.W. Parkinson's disease genetic mutations increase cell susceptibility to stress: Mutant alpha-synuclein enhances H(2)O(2)- and Sin-1-induced cell death. Neurobiol. Aging. 28 (2006) 1709-1717
20. Klivenyi P., Siwek D., Gardian G., Yang L., Starkov A., Cleren C., Ferrante R.J., Kowall N.W., Abeliovich A., and Beal M.F. Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiol. Dis. 21 (2006) 541-548
21. Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., and Masliah E. Alpha-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157 (2000) 401-410
22. Smith W.W., Jiang H., Pei Z., Tanaka Y., Morita H., Sawa A., Dawson V.L., Dawson T.M., and Ross C.A. Endoplasmic reticulum stress and mitochondrial cell death pathways mediate A53T mutant alpha-synuclein-induced toxicity. Hum. Mol. Genet. 14 (2005) 3801-3811
23. Song D.D., Shults C.W., Sisk A., Rockenstein E., and Masliah E. Enhanced substantia nigra mitochondrial pathology in human alpha-synuclein transgenic mice after treatment with MPTP. Exp. Neurol. 186 (2004) 158-172
24. Cole N.B., Murphy D.D., Grider T., Rueter S., Brasaemle D., and Nussbaum R.L. Lipid droplet binding and oligomerization properties of the Parkinson's disease protein alpha-synuclein. J. Biol. Chem. 277 (2002) 6344-6352
25. Cole N.B., Murphy D.D., Lebowitz J., Di Noto L., Levine R.L., and Nussbaum R.L. Metal-catalyzed oxidation of alpha-synuclein: helping to define the relationship between oligomers, protofibrils, and filaments. J. Biol. Chem. 280 (2005) 9678-9690
26. Tanner V.A., Ploug T., and Tao-Cheng J.H. Subcellular localization of SV2 and other secretory vesicle components in PC12 cells by an efficient method of preembedding EM immunocytochemistry for cell cultures. J. Histochem. Cytochem. 44 (1996) 1481-1488
27. Sheldon C., Cheng Y.M., and Church J. Concurrent measurements of the free cytosolic concentrations of H+ and Na+ ions with fluorescent indicators. Pflugers Arch. 449 (2004) 307-318
28. Ellis C.E., Murphy E.J., Mitchell D.C., Golovko M.Y., Scaglia F., Barcelo-Coblijn G.C., and Nussbaum R.L. Mitochondrial lipid abnormality and electron transport chain impairment in mice lacking alpha-synuclein. Mol. Cell. Biol. 25 (2005) 10190-10201
29. Hara A., and Radin N.S. Lipid extraction of tissues with a low-toxicity solvent. Anal. Biochem. 90 (1978) 420-426
30. Schlame M., Rua D., and Greenberg M.L. The biosynthesis and functional role of cardiolipin. Prog. Lipid Res. 39 (2000) 257-288
31. Johnson T.J. Aldehyde fixatives: quantification of acid-producing reactions. J. Electron. Microsc. Tech. 2 (1985) 129-138
32. Griffiths G. Fine Structure Immunocytochemistry (1993), Springer-Verlag, Heidelberg
33. Mitchell D.C., and Litman B.J. Molecular order and dynamics in bilayers consisting of highly polyunsaturated phospholipids. Biophys. J. 74 (1998) 879-891
34. Fortin D.L., Troyer M.D., Nakamura K., Kubo S., Anthony M.D., and Edwards R.H. Lipid rafts mediate the synaptic localization of alpha-synuclein. J. Neurosci. 24 (2004) 6715-6723
35. Mazzulli J.R., Mishizen A.J., Giasson B.I., Lynch D.R., Thomas S.A., Nakashima A., Nagatsu T., Ota A., and Ischiropoulos H. Cytosolic catechols inhibit alpha-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates. J. Neurosci. 26 (2006) 10068-10078
36. Sheldon C., and Church J. Intracellular pH response to anoxia in acutely dissociated adult rat hippocampal CA1 neurons. J. Neurophysiol. 87 (2002) 2209-2224
37. Archer S.L., Hampl V., Nelson D.P., Sidney E., Peterson D.A., and Weir E.K. Dithionite increases radical formation and decreases vasoconstriction in the lung. Evidence that dithionite does not mimic alveolar hypoxia. Circ. Res. 77 (1995) 174-181
38. Xu S., Zhou M., Yu S., Cai Y., Zhang A., Ueda K., and Chan P. Oxidative stress induces nuclear translocation of C-terminus of alpha-synuclein in dopaminergic cells. Biochem. Biophys. Res. Commun. 342 (2006) 330-335
39. Gores G.J., Nieminen A.L., Wray B.E., Herman B., and Lemasters J.J. Intracellular pH during "chemical hypoxia" in cultured rat hepatocytes. Protection by intracellular acidosis against the onset of cell death. J. Clin. Invest. 83 (1989) 386-396
40. Ahmad K.A., Iskandar K.B., Hirpara J.L., Clement M.V., and Pervaiz S. Hydrogen peroxide-mediated cytosolic acidification is a signal for mitochondrial translocation of Bax during drug-induced apoptosis of tumor cells. Cancer Res. 64 (2004) 7867-7878
41. Harguindey S., Reshkin S.J., Orive G., Arranz J.L., and Anitua E. Growth and trophic factors, pH and the Na+/H+ exchanger in Alzheimer's disease, other neurodegenerative diseases and cancer: new therapeutic possibilities and potential dangers. Curr. Alzheimer Res. 4 (2007) 53-65
42. Lagadic-Gossmann D., Huc L., and Lecureur V. Alterations of intracellular pH homeostasis in apoptosis: origins and roles. Cell Death Differ. 11 (2004) 953-961
43. Nilsson C., Johansson U., Johansson A.C., Kagedal K., and Ollinger K. Cytosolic acidification and lysosomal alkalinization during TNF-alpha induced apoptosis in U937 cells. Apoptosis 11 (2006) 1149-1159
44. Tsai K.L., Wang S.M., Chen C.C., Fong T.H., and Wu M.L. Mechanism of oxidative stress-induced intracellular acidosis in rat cerebellar astrocytes and C6 glioma cells. J. Physiol. 502 Pt 1 (1997) 161-174
45. Marini A.M., and Nowak Jr. T.S. Metabolic effects of 1-methyl-4-phenylpyridinium (MPP(+)) in primary neuron cultures. J. Neurosci. Res. 62 (2000) 814-820
46. Hagag N., Lacal J.C., Graber M., Aaronson S., and Viola M.V. Microinjection of ras p21 induces a rapid rise in intracellular pH. Mol. Cell. Biol. 7 (1987) 1984-1988
47. Terman A., Gustafsson B., and Brunk U.T. The lysosomal-mitochondrial axis theory of postmitotic aging and cell death. Chem. Biol. Interact. 163 (2006) 29-37
48. Thomas J.A., Buchsbaum R.N., Zimniak A., and Racker E. Intracellular pH measurements in Ehrlich ascites tumor cells utilizing spectroscopic probes generated in situ. Biochemistry 18 (1979) 2210-2218
49. Martin L.J., Pan Y., Price A.C., Sterling W., Copeland N.G., Jenkins N.A., Price D.L., and Lee M.K. Parkinson's disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J. Neurosci. 26 (2006) 41-50
50. Kim Y.S., Laurine E., Woods W., and Lee S.J. A novel mechanism of interaction between alpha-synuclein and biological membranes. J. Mol. Biol. 360 (2006) 386-397
51. Rhoades E., Ramlall T.F., Webb W.W., and Eliezer D. Quantification of alpha-synuclein binding to lipid vesicles using fluorescence correlation spectroscopy. Biophys. J. 90 (2006) 4692-4700
52. Daum G. Lipids of mitochondria. Biochim. Biophys. Acta. 822 (1985) 1-42
53. Chicco A.J., and Sparagna G.C. Role of cardiolipin alterations in mitochondrial dysfunction and disease. Am. J. Physiol., Cell. Physiol. 292 (2007) C33-C44
54. Orrenius S., Gogvadze V., and Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 47 (2007) 143-183
55. Kim T.H., Zhao Y., Ding W.X., Shin J.N., He X., Seo Y.W., Chen J., Rabinowich H., Amoscato A.A., and Yin X.M. Bid-cardiolipin interaction at mitochondrial contact site contributes to mitochondrial cristae reorganization and cytochrome C release. Mol. Biol. Cell. 15 (2004) 3061-3072
56. Garcia Fernandez M., Troiano L., Moretti L., Nasi M., Pinti M., Salvioli S., Dobrucki J., and Cossarizza A. Early changes in intramitochondrial cardiolipin distribution during apoptosis. Cell Growth Differ. 13 (2002) 449-455
57. Petit J.M., Huet O., Gallet P.F., Maftah A., Ratinaud M.H., and Julien R. Direct analysis and significance of cardiolipin transverse distribution in mitochondrial inner membranes. Eur. J. Biochem. 220 (1994) 871-879
58. Fujiki Y., Fowler S., Shio H., Hubbard A.L., and Lazarow P.B. Polypeptide and phospholipid composition of the membrane of rat liver peroxisomes: comparison with endoplasmic reticulum and mitochondrial membranes. J. Cell Biol. 93 (1982) 103-110
59. Gohil V.M., Gvozdenovic-Jeremic J., Schlame M., and Greenberg M.L. Binding of 10-N-nonyl acridine orange to cardiolipin-deficient yeast cells: implications for assay of cardiolipin. Anal. Biochem. 343 (2005) 350-352
60. Pesah Y., Pham T., Burgess H., Middlebrooks B., Verstreken P., Zhou Y., Harding M., Bellen H., and Mardon G. Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development 131 (2004) 2183-2194
61. Whitworth A.J., Theodore D.A., Greene J.C., Benes H., Wes P.D., and Pallanck L.J. Increased glutathione S-transferase activity rescues dopaminergic neuron loss in a Drosophila model of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 8024-8029
62. Clark I.E., Dodson M.W., Jiang C., Cao J.H., Huh J.R., Seol J.H., Yoo S.J., Hay B.A., and Guo M. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441 (2006) 1162-1166
63. Park J., Lee S.B., Lee S., Kim Y., Song S., Kim S., Bae E., Kim J., Shong M., Kim J.M., and Chung J. Mitochondrial dysfunction in Drosophila PINK1 mutants is complemented by parkin. Nature 441 (2006) 1157-1161
64. Yang Y., Gehrke S., Imai Y., Huang Z., Ouyang Y., Wang J.W., Yang L., Beal M.F., Vogel H., and Lu B. Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 10793-10798
65. Clements C.M., McNally R.S., Conti B.J., Mak T.W., and Ting J.P. DJ-1, a cancer- and Parkinson's disease-associated protein, stabilizes the antioxidant transcriptional master regulator Nrf2. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 15091-15096
66. Yang Y., Gehrke S., Haque M.E., Imai Y., Kosek J., Yang L., Beal M.F., Nishimura I., Wakamatsu K., Ito S., Takahashi R., and Lu B. Inactivation of Drosophila DJ-1 leads to impairments of oxidative stress response and phosphatidylinositol 3-kinase/Akt signaling. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 13670-13675
67. Allen D.G., and Orchard C.H. Myocardial contractile function during ischemia and hypoxia. Circ. Res. 60 (1987) 153-168
68. Webb J.L., Ravikumar B., Atkins J., Skepper J.N., and Rubinsztein D.C. Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278 (2003) 25009-25013
69. Devi L., Raghavendran V., Prabhu B.M., Avadhani N.G., and Anandatheerthavarada H.K. Mitochondrial import and accumulation of alpha -synuclein impairs complex I in human dopaminergic neuronal cultures and Parkinson's disease brain. J. Biol. Chem. 283 (2008) 9089-9100
70. Parihar M.S., Parihar A., Fujita M., Hashimoto M., and Ghafourifar P. Mitochondrial association of alpha-synuclein causes oxidative stress. Cell. Mol. Life. Sci. (2008)